Navigation Links
New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures

henytoin, phenobarbital, primidone, or valproate as the single AED.

Safety and effectiveness of Lamictal have not been established 1) as initial monotherapy, 2) for conversion to monotherapy from AEDs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproate, 3) for simultaneous conversion to monotherapy from 2 or more concomitant AEDs.

Lamictal is also approved for maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in adult patients treated for acute mood episodes with standard therapy. The effectiveness of Lamictal in the acute treatment of mood episodes has not been established.

Serious rashes requiring hospitalization and discontinuation of treatment have been reported in association with the use of Lamictal. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.8 percent (8 per 1000) in pediatric patients under the age of 16 years receiving Lamictal as adjunctive therapy for epilepsy, and 0.3 percent (3 per 1000) in adults on adjunctive therapy for epilepsy. In clinical trials of bipolar and other mood disorders, the rate of serious rash was 0.08 percent of adult patients who received Lamictal as initial monotherapy and 0.13 percent of adult patients who received Lamictal as adjunctive therapy. In a prospectively followed cohort of 1,983 pediatric patients taking adjunctive Lamictal, there was one rash-related death.

ABOUT GLAXOSMITHKLINE

GlaxoSmithKline, with U.S. operations in Philadelphia, P.A. and Research Triangle Park, N.C., is one of the world's leading research-based pharmaceutical and healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. More information on GlaxoSmithKline is available at the company's Web site at www.gsk.com.
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... has recently added DrugPatentWatch to its ... http://www.bharatbook.com/drugpatentwatch-tour.pdf )      (Logo: ... comprehensive information on pharmaceutical, drug patents ... supports the critical business functions of ...
(Date:6/19/2013)... -- DST Health Solutions, LLC (DSTHS), a leading provider ... delivery systems, and health care providers, has announced that ... has jumped significantly. A customizable solution ... medical prescription drug claims, MDMS allows health ... claims processes. As specialty drug demand grows due to ...
(Date:6/19/2013)... Calif. , June 19, 2013   ... today announces a licensing agreement granting Suzhou Ribo ... and manufacture siRNA therapeutics in China ...  Ribo will formulate proprietary siRNA molecules in combination ... designed to address human diseases with high unmet ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
... medical device company focused on developing unique modular spinal fusion ... a 97% sales increase for 2010 versus 2009, with a ... the prior-year period.  The company also reports an average growth ... RSB Spine Chief Executive Officer John A. Redmond said: "It ...
... The Alpha-1 Foundation announced today that it has awarded ... to our understanding of the causes and mechanisms that ... investigate how cigarette smoke promotes the onset of emphysema ... and how the alpha(1)-proteinase inhibitor (A1PI) protein protects the ...
Cached Medicine Technology:Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 2Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 3Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 4
(Date:6/19/2013)... 19, 2013 HASCO Medical, Inc. ... its intent to purchase privately held Auto Mobility ... in wheelchair accessible vehicle sales, service and rentals ... Sales, Inc compliments and expands HASCO's strategy of ... mobility dealers . The acquisition is subject to ...
(Date:6/19/2013)... 2013 Brain not working? Functional medicine ... why such seemingly minor brain problems as brain fog, ... red flags. They indicate the brain may be degenerating—or ... Alzheimer’s, Parkinson’s, stroke, and other neurological diseases. Why ... by Elephant Press is now available online at ...
(Date:6/19/2013)... City, Utah (PRWEB) June 19, 2013 ... Wisconsin Health Insurance Exchange . Zane Benefits, which ... health benefits, is the leader in defined contribution ... According to Zane Benefits’ website, as part of the ... and small businesses will become available through new state ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 According to a ... Surviving Weekend Sunburn,” it is not uncommon for a person ... summer months. A person is likely to forget to reapply ... which is both dry and itchy. When this occurs, it ... to goo.gl/gDyjP). , “Most people do not realize that milk ...
(Date:6/19/2013)... (June 19, 2013) In what is believed to ... most common form of hereditary dystonia a movement ... in deep brain stimulation report good success rates and ... the Movement Disorders Program at Cedars-Sinai Medical Center,s Department ... the Division of Neurosurgery at Beth Israel Deaconess Medical ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Skin Care – How to treat Sunburn 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2
... January 7, Discovery Health Presents Five Nights of Active, Viewing ... ... FIT TO LIVE -, SILVER SPRING, Md., Dec. 11 ... annual,weight loss and general wellness campaign-launches with a four-part,television event following ...
... American Red Cross Provides Tips on What to Do ... Dec. 11 American Red Cross,chapters throughout the Midwest ... outages and a frozen landscape, despite several,chapter offices being ... and employees are working from home or using partnerships ...
... Dec. 11 AIDS Healthcare,Foundation (AHF) today blasted ... Huckabee, for his stubbornness and,recent failure to apologize ... campaign in which he called for people living ... At the time, Huckabee,told Associated Press in response ...
... Consumers with Unaffordable Mandate, SANTA MONICA, Calif., Dec. ... as 14% have led a state panel,to propose a ... The vote,came less than a month before every citizen ... penalties that increase monthly, and as,California politicians and labor ...
... Party to Commit to Creating,Evidence Based National HIV/AIDS ... released a,statement today calling on Presidential Candidate Mike ... the policies he would undertake as,President conform to ... HIV. "Governor Huckabee,s 1992 statement calling for the,quarantine ...
... Nature, Brandeis University Howard Hughes Medical Investigator Dr. Dorothee ... secret lives of enzymes, the ubiquitous proteins that catalyze ... sophisticated technologies to capture a key enzyme changing shape ... that these proteins are not the wallflowers of the ...
Cached Medicine News:Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 2Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 3Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 4Health News:Darkness and Cold Prevail in the Midwest 2Health News:Darkness and Cold Prevail in the Midwest 3Health News:Darkness and Cold Prevail in the Midwest 4Health News:Huckabee's Defense of Earlier, Alarmist AIDS Stance Shows Unsuitability for Presidency, Says AHF 2Health News:Double-Digit Rate Increases Expected Under Mass. Mandatory Health Law; 5% Cap on Rate Hikes Proposed 2Health News:AIDS Action Calls on Huckabee to Follow HIV/AIDS Science 2Health News:Caught in the act: The dynamic dance of enzymes 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: